Company research projects supported by PIPE Program

• Abstract

  The use of immunodiagnostic kits is one of the fast and safe tools for early treatment of human diseases. To develop these kits, at first, it's necessary the production of recombinant proteins or peptides specific to pathogens (targets) with high purity and that replicate the structural and conformal characteristics of the native protein, and in a second moment, monoclonal antibodies with…

  Production of STC-1 protein and monoclonal antibodies for therapeutic or clinical response monitoring in acute lymphoblastic leukemia, AP.PIPE

• Abstract

  The use of immunodiagnosis kits is one of the quickest and safest bets for early treatment of human diseases. The production of these kits entails, first of all, generating proteins or recombinant peptides of specific targets of the referred pathogens, with high levels of purity and mimickry of the native protein's structural and conformational characteristics, and in the second place, hi…

  Production of STC-1 protein and monoclonal antibodies for therapeutic or clinical response monitoring in acute lymphoblastic leukemia, AP.PIPE
• Antibodies production for immunochemical methods: market insertion, AP.PIPE3

(Only some records are available in English at this moment)